INSIGHTS ON DRUG DEVELOPMENT

• Quantification Of Exenatide Using Xevo TQD

  Discover a highly sensitive and reliable LC-MS/MS method for quantifying exenatide in plasma that is powered by advanced sample prep and optimized column chemistries.

• 3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems

  Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.

• Driving Efficiency Through Process Intensification

  Discover how intensification strategies reduce costs and waste while boosting throughput, sustainability, and operational value, which offers a smarter, more scalable approach to manufacturing.

• AAV Downstream Challenges: Expert Insights

  Gain expert insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.

• When And How To Implement Process Intensification

  10/3/2025

  Explore when to intensify your processes, what challenges to expect, and how to prepare for a successful transition with expert insights to help guide your strategy and ensure smoother implementation.

• Inside The Development Of An AAV8 Production Platform

  4/24/2025

  Explore innovative solutions for AAV8 production challenges, which include scalability and purity, as well as learn how a collaboration with CDMO Matica Biotechnology ensures efficient, high-yield gene therapy vector production.

• Multifactorial Disease Models: De-Risking Topical Formulation Development

  10/20/2025

  Traditional drug models fail to predict performance in human skin. Advanced, multifactorial ex vivo disease models directly address inflammation and infection to significantly de-risk formulation development.

• Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids

  3/31/2025

  Using CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.

• DSS-Induced IBD Mouse Model For Preclinical Drug Screening

  3/27/2025

  Leverage our chemically induced murine model of Inflammatory Bowel Disease to accelerate your research on IBD and explore potential therapeutic interventions.